0001144204-19-001143.txt : 20190108
0001144204-19-001143.hdr.sgml : 20190108
20190108195110
ACCESSION NUMBER: 0001144204-19-001143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190108
FILED AS OF DATE: 20190108
DATE AS OF CHANGE: 20190108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boothe Douglas
CENTRAL INDEX KEY: 0001566118
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32360
FILM NUMBER: 19517055
MAIL ADDRESS:
STREET 1: C/O IMPAX LABORATORIES, INC.
STREET 2: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKORN INC
CENTRAL INDEX KEY: 0000003116
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 720717400
STATE OF INCORPORATION: LA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1925 W. FIELD COURT, SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: 847-279-6100
MAIL ADDRESS:
STREET 1: 1925 W. FIELD COURT, SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
tv510640_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-01-08
0
0000003116
AKORN INC
AKRX
0001566118
Boothe Douglas
C/O AKORN, INC.
1925 W. FIELD COURT, SUITE 300
LAKE FOREST
IL
60045
0
1
0
0
President and CEO
Common Stock
2019-01-08
4
A
0
507614
0
A
507614
D
Stock Options (Right to Buy)
3.94
2019-01-08
4
A
0
405938
0
A
2029-01-08
Common Stock
405938
405938
D
Performance Share Units
2019-01-08
4
A
0
253807
0
A
Common Stock
253807
253807
D
The securities acquired are Restricted Stock Units (RSUs) scheduled to vest in four equal installments on January 8, 2020, January 8, 2021, January 8, 2022 and January 8, 2023.
The Stock Options vest in four equal installments on January 8, 2020, January 8, 2021, January 8, 2022 and January 8, 2023.
Each Performance Share Unit (PSU) represents a contingent right to receive one share of Akorn common stock. The PSUs will vest at the end of a four-year performance period on January 7, 2023 at between 0% and 300% of target based upon the achievement of a specified price of Akorn's common stock (from $8 to $20), subject to continued service through the date of settlement.
/s/ Joseph Bonaccorsi, Attorney-in-Fact
2019-01-08